Great — below is a concise, sourced market reference pack for the Membrane Filtration Market with company references + the best publicly available company revenue values I could find, followed by the analysis sections you requested. I pulled recent market reports and corporate filings (2024/2025) and cite the most important sources.

This versatile research report is presenting crucial details on market relevant information, harping on ample minute details encompassing a multi-dimensional market that collectively maneuver growth in the global Membrane Filtration market.

This holistic report presented by the report is also determined to cater to all the market specific information and a take on business analysis and key growth steering best industry practices that optimize million-dollar opportunities amidst staggering competition in Membrane Filtration market.

Read complete report at: https://www.thebrainyinsights.com/report/membrane-filtration-market-13211

Quick market snapshot

  • Reported global market size estimates (2024 base-year) vary by source — examples: USD ~18.8–21.3 billion (2024) with mid-to-high single-digit to ~9–9.5% CAGR projections into the 2030s depending on the report.

Key companies — company reference + public revenue / value (latest public FY / annual numbers I found)

Most vendors do not disclose membrane-only revenue separately; I list each company with the company/segment-level revenue (FY 2024 / 2024–25 filings) and a short note on their membrane role.

  1. Danaher Corporation (Pall Corporation / filtration & life-science filtration) — Revenue (FY 2024): $23.9 billion (Danaher consolidated). Danaher’s Pall business is a major global supplier of membrane filtration products for biopharma, industrial and aerospace applications.

  2. Sartorius (Sartorius Stedim / bioprocess filtration) — Sales revenue (FY 2024): €3,381 million (~€3.38B). Sartorius is a leading supplier of membranes and filtration systems for biopharma and life-science applications.

  3. Merck KGaA / MilliporeSigma — Merck Group net sales (2024): €21.2 billion (Life Science and Electronics divisions supply membranes, cartridges, and filtration consumables used in biotech, pharma and industrial processes).

  4. Toray Industries — Consolidated revenue (FY ended Mar 31, 2025): ¥2,563,280 million (~JPY 2.56 trillion); Toray is a leading manufacturer of polymeric and RO membranes (water treatment, desalination, industrial).

  5. DuPont (Water Solutions & related units) — Net sales (FY 2024 / pro forma): ~$12.4 billion (company net sales ~2024); DuPont supplies membrane materials (RO/NF elements, specialty polymeric membranes) and water-treatment components. (DuPont’s Water business is a named growth area in recent results.)

  6. Evoqua Water Technologies — Revenue (TTM / 2024–2025): ~USD 1.8–1.9 billion; Evoqua supplies membrane systems, RO plants and integrated water-treatment services.

  7. Pentair — Full-year sales (2024): ~$4.08 billion; Pentair’s Water Solutions include membrane-based residential and industrial filtration products.

  8. Nitto Denko (membrane business / high-polymer separation membranes) — Group revenue (FY 2024/2025): ~¥1.01 trillion (company reports show membrane as a material business within Life Science / Industrial segments). Nitto is a supplier of specialty membranes and separation materials.

  9. SUEZ / Veolia (water technology & membrane solutions) — Major global water-services groups operating membrane treatment, desalination and industrial RO projects; revenue shown in each company’s FY2024 investor materials (group level). Veolia and SUEZ are important project/system integrators for large membrane deployments. 

Note: the numbers above are company/segment or consolidated revenues used as the closest public proxy for company size — membrane-specific revenue is rarely broken out publicly. I included authoritative annual reports and investor presentations as sources.

Recent developments (2023–2025)

  • Several market studies and press releases point to accelerating demand for membranes across water & wastewater treatment, desalination, food & beverage, and biopharma downstream/upstream processing — driven by tougher water reuse rules and pharma/bio manufacturing growth. Multiple market reports published in 2024–2025 increase market-size estimates and forecast healthy CAGRs.

Drivers

  • Rising need for potable water, desalination and wastewater reuse (municipal & industrial) — drives RO, NF, UF membrane deployments. 

  • Expansion of biologics and bioprocessing (filtration/sterile separations) — increases demand for life-science grade membranes and single-use filtration equipment.

  • Industrial process filtration (food & beverage, chemical, semiconductor) and tightening regulations (effluent, PFAS removal) fueling membrane adoption. 

Restraints

  • Capital intensity of large membrane projects (desalination/industrial RO) and cyclical capex budgets in end-markets.

  • Fouling, scaling and overall lifecycle OPEX (energy + membrane replacement) remain technical & cost constraints in some deployments.

  • Fragmented supplier base for specific membrane chemistries — customers sometimes require long qualification cycles. 

Regional segmentation analysis

  • Asia-Pacific: largest volume market and fastest growth (large desalination investments, municipal reuse projects, strong industrial demand in China, India, Southeast Asia). 

  • North America: strong growth in industrial water reuse, PFAS remediation pilots, and replacement/retrofit markets; sizable biopharma filtration demand.

  • Europe: mature market with steady municipal & industrial projects and strong regulatory drivers for reuse and circularity.

  • MEA & Latin America: desalination and water scarcity projects drive RO demand (project-driven).

Emerging trends

  • Advanced membrane chemistries & ceramic membranes for harsh industrial streams and higher thermal/chemical resistance.

  • Energy-efficient RO / low-pressure membranes and hybrid processes (membrane + electrochemical) to lower lifecycle costs.

  • Single-use / modular membrane systems for biopharma and decentralised water treatment (rapid deployment, lower CAPEX).

Top use cases

  1. Desalination & municipal water-reuse (RO, NF).

  2. Biopharmaceutical downstream & sterile filtration (UF/0.2 µm filters, tangential flow).

  3. Industrial process water & wastewater treatment (UF/NF/RO).

  4. Food & beverage clarification and dairy processing (MF/UF).

Major challenges

  • Membrane fouling & lifecycle costs (cleaning frequency, chemicals, downtime).

  • Energy intensity of high-rejection RO systems and need for integration with energy recovery devices.

  • Long project procurement/qualification cycles — especially for pharma/biotech customers. 

Attractive opportunities

  • Retrofit & upgrade projects (replacing legacy membranes with higher-efficiency elements).

  • Decentralized / modular wastewater reuse for industry and small municipalities.

  • PFAS/NF-based remediation & industrial specialty membranes (niche, high-value).

  • Bio/pharma single-use membrane consumables & services (recurring revenue).

Key factors of market expansion

  • Government investments in water infrastructure and reuse mandates.

  • Continued growth in biologics and vaccine manufacturing (driving demand for process filtration).

  • R&D progress lowering energy and fouling issues (better polymeric and ceramic membranes).

  • Greater adoption of integrated service models (O&M + membrane-as-a-service).

Sources (high-impact / where I pulled the company numbers and market figures)

  • Market reports: Polaris Market Research / Maximize Market Research / Precedence Research (membrane filtration & water-membrane market sizing and forecasts).

  • Danaher 2024 Annual Report (group revenue $23.9B; Pall filtration business context).

  • Sartorius FY2024 results / fact sheet (sales €3,381M; bioprocess filtration).

  • Merck KGaA annual/press materials (Merck Group net sales 2024 €21.2B; Life Science/electronics divisions supply filtration products).

  • Toray consolidated financial statements / product announcements (Toray membranes & FY figures).

  • Evoqua Water Technologies (public filings / quarterly pages; revenue ~USD1.8–1.9B TTM).

  • Pentair FY2024 results (full-year sales ~$4.08B).

  • Nitto Denko integrated report (membrane business commentary & FY metrics).

  • SUEZ / Veolia investor presentations and news for water-project integration context.

Would you like this converted into a downloadable vendor table (CSV) showing: company | HQ | FY-2024 revenue (public) | membrane role (RO/UF/ceramic/bioprocess) | source link?
If yes, I’ll build the CSV now and attach it.